Etravirine

Intelence

Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor

NADAC/unit $7.7671

No Shortage Tier 1: 55.6% 3 Manufacturers 6 ANDAs

vs. brand Intelence: Generic saves up to 22% per unit

Covered Lives

Generic Manufacturers

AMNEAL EU LTDBIONPHARMA INCCARNEGIE PHARMACEUTICALS LLCJANSSEN RESEARCH AND DEVELOPMENT LLC

Explore in the Ecosystem

rxsaver.aiCompare prices for Etravirine drfinder.aiFind doctors who prescribe Etravirine rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Etravirine

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.